Artesunate v. quinine for severe malaria

South African Medical Journal

Volumn 103, Issue 5, 2013, Pages 274-

  Naidoo, Poobalan ^a   Saman, S ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; QUININE;

CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOGLYCEMIA; LETTER; MALARIA; MALARIA FALCIPARUM; META ANALYSIS (TOPIC); MORTALITY; OUTCOME ASSESSMENT;

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA, FALCIPARUM; QUININE; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA;

EID: 84877659282     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.6777     Document Type: Letter

References (3)

1. Trampuz A, Jereb M, Muzlovic I, Prabhu RM. Clinical review: Severe malaria. Crit Care 2003;7(4):315-323.
2. Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012 Jun Cochrane Database Syst Rev. 2012 Jun 13; 6:CD005967. [http://dx.doi.org/10.1002/14651858.CD005967.pub4]
3. Visser Kift E, Kredo T, Barnes KI. Parenteral artesunate access programme aims at reducing malaria fatality rates in South Africa. S Afr Med J 2011;101(4):240-241.